Tower Research Capital (TRC)’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$30.2K Buy
2025
Q1
$19.7K Buy
2024
Q4
$4.08K Sell
2024
Q3
$31.1K Buy
2024
Q2
$26.5K Sell
2024
Q1
$49.4K Sell
2023
Q4
$186K Buy
2023
Q3
$33.7K Buy
2023
Q2
$46K Sell
2023
Q1
$40K Buy
2022
Q4
$7K Buy